Clinical Trials Browser

Escitalopram × Head & Neck × Clear all

NCT00536172 2023-09-21

PROTECT

Phase 4 Completed

160 enrolled 15 charts

Depression, Depressive Disorder, Major, Head and Neck Neoplasms

NCT00935675 2009-09-02

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment

Phase 3 Unknown

Squamous Cell Carcinoma of Head and Neck, Carcinoma